Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$36.95 - $82.41 $139,227 - $310,520
-3,768 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$135.05 - $182.59 $212,028 - $286,666
-1,570 Reduced 29.41%
3,768 $561,000
Q3 2021

Nov 05, 2021

BUY
$145.58 - $192.14 $6,696 - $8,838
46 Added 0.87%
5,338 $777,000
Q2 2021

Aug 06, 2021

BUY
$134.22 - $202.37 $318,638 - $480,426
2,374 Added 81.36%
5,292 $1.04 Million
Q1 2021

May 03, 2021

BUY
$140.25 - $196.86 $55,679 - $78,153
397 Added 15.75%
2,918 $528,000
Q4 2020

Feb 04, 2021

BUY
$126.47 - $163.7 $318,830 - $412,687
2,521 New
2,521 $357,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.